[1]
|
邹小农, 贾漫漫, 王鑫, 支修益. 《2020全球癌症报告》要点解读[J]. 中国胸心血管外科临床杂志, 2021, 28(1): 11-18.
|
[2]
|
Chen, W., Zheng, R., Baade, P.D., Zhang, S., Zeng, H., Bray, F., et al. (2016) Cancer Statistics in China, 2015. CA: A Cancer Journal for Clinicians, 66, 115-132. https://doi.org/10.3322/caac.21338
|
[3]
|
van Dalen, E.C., van der Pal, H.J.H., Kok, W.E.M., Caron, H.N. and Kremer, L.C.M. (2006) Clinical Heart Failure in a Cohort of Chil-dren Treated with Anthracyclines: A Long-Term Follow-Up Study. European Journal of Cancer, 42, 3191-3198. https://doi.org/10.1016/j.ejca.2006.08.005
|
[4]
|
Mulrooney, D.A., Yeazel, M.W., Kawashima, T., Mertens, A.C., Mitby, P., Stovall, M., et al. (2009) Cardiac Outcomes in a Cohort of Adult Survivors of Childhood and Adolescent Cancer: Retrospective Analysis of the Childhood Cancer Survivor Study Cohort. BMJ, 339, Article No. b4606. https://doi.org/10.1136/bmj.b4606
|
[5]
|
Herrmann, J. (2020) Adverse Cardiac Effects of Cancer Therapies: Cardio-toxicity and Arrhythmia. Nature Reviews Cardiology, 17, 474-502. https://doi.org/10.1038/s41569-020-0348-1
|
[6]
|
McGowan, J.V., Chung, R., Maulik, A., Piotrowska, I., Walker, J.M. and Yellon, D.M. (2017) Anthracycline Chemotherapy and Cardiotoxicity. Cardiovascular Drugs and Therapy, 31, 63-75. https://doi.org/10.1007/s10557-016-6711-0
|
[7]
|
Shabalala, S., Muller, C.J.F., Louw, J. and Johnson, R. (2017) Polyphenols, Autophagy and Doxorubicin-Induced Cardiotoxicity. Life Sciences, 180, 160-170. https://doi.org/10.1016/j.lfs.2017.05.003
|
[8]
|
Ferreira de Souza, T., Quinaglia AC Silva, T., Osorio Costa, F., Shah, R., Neilan, T. G., Velloso, L., et al. (2018) Anthracycline Therapy Is Associated with Cardiomyocyte Atrophy and Pre-clinical Manifestations of Heart Disease. JACC: Cardiovascular Imaging, 11, 1045-1055. https://doi.org/10.1016/j.jcmg.2018.05.012
|
[9]
|
Swain, S.M., Whaley, F.S. and Ewer, M.S. (2003) Congestive Heart Failure in Patients Treated with Doxorubicin: A Retrospective Analysis of Three Trials. Cancer, 97, 2869-2879. https://doi.org/10.1002/cncr.11407
|
[10]
|
Bristow, M.R., Thompson, P.D., Martin, R.P., Mason, J.W., Billingham, M.E. and Harrison, D.C. (1978) Early Anthracycline Cardiotoxicity. The American Journal of Medicine, 65, 823-832.
https://doi.org/10.1016/0002-9343(78)90802-1
|
[11]
|
Gottdiener, J.S., Appelbaum, F.R., Ferrans, V.J., Deisseroth, A. and Ziegler, J. (1981) Cardiotoxicity Associated with High-Dose Cyclophosphamide Therapy. Archives of Internal Medicine, 141, 758-763.
https://doi.org/10.1001/archinte.1981.00340060066015
|
[12]
|
Zamorano, J.L., Lancellotti, P., Rodriguez Muñoz, D., Aboyans, V., Asteggiano, R., Galderisi, M., et al. (2016) 2016 ESC Position Paper on Cancer Treatments and Cardio-vascular Toxicity Developed under the Auspices of the ESC Committee for Practice Guidelines: The Task Force for Cancer Treatments and Cardiovascular Toxicity of the European Society of Cardiology (ESC). European Heart Journal, 37, 2768-2801. https://doi.org/10.1093/eurheartj/ehw211
|
[13]
|
Ewer, M.S. and Ewer, S.M. (2015) Cardiotoxicity of anticancer treatments. Nature Reviews Cardiology, 12, 547-558.
https://doi.org/10.1038/nrcardio.2015.65
|
[14]
|
Martel, S., Maurer, C., Lambertini, M., Pondé, N. and De Azambuja, E. (2017) Breast Cancer Treatment-Induced Cardiotoxicity. Expert Opinion on Drug Safety, 16, 1021-1038. https://doi.org/10.1080/14740338.2017.1351541
|
[15]
|
Fanous, I. and Dillon, P. (2016) Cancer Treatment-Related Cardiac Toxicity: Prevention, Assessment and Management. Medical Oncology, 33, Article No. 84. https://doi.org/10.1007/s12032-016-0801-5
|
[16]
|
Jerusalem, G., Moonen, M., Freres, P. and Lancellotti, P. (2015) The European Association of Cardiovascular Imaging/heart Failure Association Cardiac Oncology Toxicity Registry: Long-Term Benefits for Breast Cancer Treatment. Future Oncology, 11, 2791-2794. https://doi.org/10.2217/fon.15.227
|
[17]
|
Giordano, G., Spagnuolo, A., Olivieri, N., Corbo, C., Campagna, A., Spagnoletti, I., et al. (2016) Cancer Drug Related Cardiotoxicity during Breast Cancer Treatment. Expert Opinion on Drug Safety, 15, 1063-1074.
https://doi.org/10.1080/14740338.2016.1182493
|
[18]
|
Pondé, N.F., Lambertini, M. and de Azambuja, E. (2016) Twenty Years of Anti-HER2 Therapy-Associated Cardiotoxicity. ESMO Open, 1, e000073. https://doi.org/10.1136/esmoopen-2016-000073
|
[19]
|
Barish, R., Gates, E. and Barac, A. (2019) Trastuzumab-Induced Cardiomyopathy. Cardiology Clinics, 37, 407-418.
https://doi.org/10.1016/j.ccl.2019.07.005
|
[20]
|
Dunet, V., Schwitter, J., Meuli, R. and Beigelman-Aubry, C. (2016) Incidental Extracardiac Findings on Cardiac MR: Systematic Review and Meta-Analysis. Journal of Magnetic Resonance Imaging, 43, 929-939.
https://doi.org/10.1002/jmri.25053
|
[21]
|
Lambert, J., Lamacie, M., Thampinathan, B., Altaha, M.A., Esmaeilzadeh, M., Nolan, M., et al. (2020) Variability in Echocardiography and MRI for Detection of Cancer Therapy Cardiotoxicity. Heart, 106, 817-823.
https://doi.org/10.1136/heartjnl-2019-316297
|
[22]
|
Halliday, B.P., Senior, R. and Pennell, D.J. (2021) Assessing Left Ventricular Systolic Function: From Ejection Fraction to Strain Analysis. European Heart Journal, 42, 789-797. https://doi.org/10.1093/eurheartj/ehaa587
|
[23]
|
Plana, J.C., Galderisi, M., Barac, A., Ewer, M.S., Ky, B., Scher-rer-Crosbie, M., et al. (2014) Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovas-cular Imaging. Journal of the American Society of Echocardiography, 27, 911-939. https://doi.org/10.1016/j.echo.2014.07.012
|
[24]
|
Ewer, M.S., Ali, M.K., Mackay, B., Wallace, S., Valdivieso, M., Legha, S.S., et al. (1984) A Comparison of Cardiac Biopsy Grades and Ejection Fraction Estimations in Patients Receiv-ing Adriamycin. Journal of Clinical Oncology, 2, 112-117. https://doi.org/10.1200/JCO.1984.2.2.112
|
[25]
|
Jolly, M.-P., Jordan, J.H., Meléndez, G.C., McNeal, G.R., D’Agostino, R.B. and Hundley, W.G. (2017) Automated Assess-ments of Circumferential Strain from Cine CMR Correlate with LVEF Declines in Cancer Patients Early after Receipt of Cardio-Toxic Chemotherapy. Journal of Cardiovascular Magnetic Resonance, 19, Article No. 59.
https://doi.org/10.1186/s12968-017-0373-3
|
[26]
|
Gottbrecht, M., Kramer, C.M. and Salerno, M. (2019) Native T1 and Extracellular Volume Measurements by Cardiac MRI in Healthy Adults: A Meta-Analysis. Radiology, 290, 317-326. https://doi.org/10.1148/radiol.2018180226
|
[27]
|
Giusca, S., Korosoglou, G., Montenbruck, M., Gersak, B., Schwarz, A.K., Esch, S., et al. (2021) Multiparametric Early Detection and Prediction of Cardiotoxicity Using Myocardi-al Strain, T1 and T2 Mapping, and Biochemical Markers: A Longitudinal Cardiac Resonance Imaging Study During 2 Years of Follow-up. Circulation: Cardiovascular Imaging, 14, e012459. https://doi.org/10.1161/CIRCIMAGING.121.012459
|
[28]
|
Pituskin, E., Mackey, J.R., Koshman, S., Jassal, D., Pitz, M., Haykowsky, M.J., et al. (2017) Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101-Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity. Journal of Clinical Oncology, 35, 870-877.
https://doi.org/10.1200/JCO.2016.68.7830
|
[29]
|
Neilan, T.G., Coelho-Filho, O.R., Pena-Herrera, D., Shah, R.V., Jerosch-Herold, M., Francis, S.A., et al. (2012) Left Ventricular Mass in Patients with a Cardiomyopathy after Treatment with Anthracyclines. The American Journal of Cardiology, 110, 1679-1686. https://doi.org/10.1016/j.amjcard.2012.07.040
|
[30]
|
Barthur, A., Brezden-Masley, C., Connelly, K.A., Dhir, V., Chan, K.K.W., Haq, R., et al. (2017) Longitudinal Assessment of Right Ventricular Structure and Function by Cardio-vascular Magnetic Resonance in Breast Cancer Patients Treated with Trastuzumab: A Prospective Observational Study. Journal of Cardiovascular Magnetic Resonance, 19, Article No. 44. https://doi.org/10.1186/s12968-017-0356-4
|
[31]
|
Ylänen, K., Poutanen, T., Savikurki-Heikkilä, P., Rinta-Kiikka, I., Eerola, A. and Vettenranta, K. (2013) Cardiac Magnetic Resonance Imaging in the Evaluation of the Late Effects of Anthracyclines Among Long-Term Survivors of Childhood Cancer. Journal of the American College of Cardiology, 61, 1539-1547.
https://doi.org/10.1016/j.jacc.2013.01.019
|
[32]
|
Chang, W.-T., Shih, J.-Y., Feng, Y.-H., Chiang, C.-Y., Kuo, Y.H., Chen, W.-Y., et al. (2016) The Early Predictive Value of Right Ventricular Strain in Epirubicin-Induced Cardiotoxicity in Patients with Breast Cancer. Acta Cardiological Sinica, 32, 550-559.
|
[33]
|
Chen, L., Huang, J., Wu, W., Ta, S. and Xie, X. (2019) The Impact of Right Ventricular Function on Prognosis in Patients with Stage III Non-Small Cell Lung Cancer after Concurrent Chemoradiotherapy. The International Journal of Cardiovascular Imaging, 35, 1009-1017. https://doi.org/10.1007/s10554-019-01590-0
|
[34]
|
de Ville de Goyet, M., Brichard, B., Robert, A., Renard, L., Veyckemans, F., Vanhoutte, L. and Moniotte, S. (2015) Prospective Cardiac MRI for the Analysis of Biventricular Function in Children Undergoing Cancer Treatments. Pediatric Blood & Cancer, 62, 867-874. https://doi.org/10.1002/pbc.25381
|
[35]
|
Evin, M., Cluzel, P., Lamy, J., Rosenbaum, D., Kusmia, S., Defrance, C., et al. (2015) Assessment of Left Atrial Function by Mri Myocardial Feature Tracking. Journal of Magnetic Resonance Im-aging, 42, 379-389.
https://doi.org/10.1002/jmri.24851
|
[36]
|
Messroghli, D.R., Moon, J.C., Ferreira, V.M., Grosse-Wortmann, L., He, T., Kellman, P., et al. (2017) Clinical Recommendations for Cardiovascular Magnetic Resonance Mapping of T1, T2, T2* and Extracellular Volume: A Consensus Statement by the Society for Cardiovascular Magnetic Resonance (SCMR) En-dorsed by the European Association for Cardiovascular Imaging (EACVI). Journal of Cardiovascular Magnetic Reso-nance, 19, Article No. 75.
https://doi.org/10.1186/s12968-017-0389-8
|
[37]
|
Soufer, A. and Baldassarre, L.A. (2019) The Role of Cardiac Magnetic Resonance Imaging to Detect Cardiac Toxicity from Cancer Therapeutics. Current Treatment Options in Car-diovascular Medicine, 21, Article No. 28.
https://doi.org/10.1007/s11936-019-0732-5
|
[38]
|
Park, C.J., Branch, M.E., Vasu, S. and Melendez, G.C. (2020) The Role of Cardiac MRI in Animal Models of Cardiotoxicity: Hopes and Challenges. Journal of Cardiovascular Translational Research, 13, 367-376.
https://doi.org/10.1007/s12265-020-09981-8
|
[39]
|
Haslbauer, J.D., Lindner, S., Valbuena-Lopez, S., Zainal, H., Zhou, H., D’Angelo, T., et al. (2019) CMR Imaging Biosignature of Cardiac Involvement Due to Cancer-Related Treat-ment by T1 and T2 Mapping. International Journal of Cardiology, 275, 179-186. https://doi.org/10.1016/j.ijcard.2018.10.023
|
[40]
|
Hong, Y.J., Park, H.S., Park, J.K., Han, K., Park, C.H., Kim, T.K., et al. (2017) Early Detection and Serial Monitoring of Anthracycline-Induced Cardiotoxicity Using T1-Mapping Cardiac Magnetic Resonance Imaging: An Animal Study. Scientific Reports, 7, Article No. 2663. https://doi.org/10.1038/s41598-017-02627-x
|
[41]
|
Galán-Arriola, C., Lobo, M., Vílchez-Tschischke, J.P., López, G.J., de Molina-Iracheta, A., Pérez-Martínez, C., et al. (2019) Serial Magnetic Resonance Imaging to Identify Early Stages of Anthracycline-Induced Cardiotoxicity. Journal of the American College of Cardiology, 73, 779-791. https://doi.org/10.1016/j.jacc.2018.11.046
|
[42]
|
Modi, K., Joppa, S., Chen, K.-H.A., Athwal, P.S.S., Okasha, O., Velangi, P.S., et al. (2020) Myocardial Damage Assessed by Late Gadolinium Enhancement on Cardiovascular Magnetic Resonance Imaging in Cancer Patients Treated with Anthracyclines and/or Trastuzumab. European Heart Jour-nal-Cardiovascular Imaging, 22, 427-434.
https://doi.org/10.1093/ehjci/jeaa279
|
[43]
|
Lightfoot, J.C., D’Agostino Jr., R.B., Hamilton, C.A., Jordan, J., Torti, F.M., Kock, N.D., et al. (2010) Novel Approach to Early Detection of Doxorubicin Cardiotoxicity by Gadolini-um-Enhanced Cardiovascular Magnetic Resonance Imaging in an Experimental Model. Circulation: Cardiovascular Im-aging, 3, 550-558.
https://doi.org/10.1161/CIRCIMAGING.109.918540
|
[44]
|
Varricchi, G., Ameri, P., Cadeddu, C., Ghigo, A., Ma-donna, R., Marone, G., et al. (2018) Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective. Frontiers in Physiology, 9, Article 167.
https://doi.org/10.3389/fphys.2018.00167
|
[45]
|
Greenwood, J.P., Maredia, N., Younger, J.F., Brown, J.M., Nixon, J., Everett, C.C., et al. (2012) Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography for Diagnosis of Coronary Heart Disease (CE-MARC): A Prospective Trial. Lancet, 379, 453-460. https://doi.org/10.1016/S0140-6736(11)61335-4
|
[46]
|
Lipinski, M.J., McVey, C.M., Berger, J.S., Kramer, C.M. and Salerno, M. (2013) Prognostic Value of Stress Cardiac Magnetic Resonance Imaging in Patients with Known or Suspected Coronary Artery Disease: A Systematic Review and Meta-Analysis. Journal of the American College of Car-diology, 62, 826-838.
https://doi.org/10.1016/j.jacc.2013.03.080
|
[47]
|
Schwitter, J., Wacker, C.M., Wilke, N., Al-Saadi, N., Sauer, E., Huettle, K., et al. (2013) MR-IMPACT II: Magnetic Resonance Imaging for Myocardial Perfusion Assessment in Coro-nary Artery Disease Trial: Perfusion-Cardiac Magnetic Resonance vs. Single-Photon Emission Computed Tomography for the Detection of Coronary Artery Disease: A Comparative Multicentre, Multivendor Trial. European Heart Journal, 34, 775-781.
https://doi.org/10.1093/eurheartj/ehs022
|
[48]
|
Pack, N.A. and DiBella, E.V.R. (2010) Comparison of Myocardial Perfusion Estimates from Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Four Quantitative Analysis Methods. Magnetic Resonance in Medicine, 64, 125-137. https://doi.org/10.1002/mrm.22282
|
[49]
|
Nguyen, V.B.L. (2018) Stress Cardiovascular Magnetic Resonance for Evaluation of Antineoplastic Associated Cardiotoxicity in a Re-al-World Cohort of Breast Cancer Patients. Society of Cardiovascular Magnetic Resonance Scientific Sessions.
|
[50]
|
Liu, A., Wijesurendra, R.S., Liu, J.M., Greiser, A., Jerosch-Herold, M., Forfar, J.C., et al. (2018) Gadolinium-Free Cardiac MR Stress T1-Mapping to Distinguish Epicardial from Microvascular Coronary Disease. Journal of the American Col-lege of Cardiology, 71, 957-968. https://doi.org/10.1016/j.jacc.2017.11.071
|
[51]
|
Boutouyrie, P., Tropeano, A.I., Asmar, R., Gautier, I., Benetos, A., Lacolley, P., et al. (2002) Aortic Stiffness Is an Independent Predictor of Primary Coronary Events in Hypertensive Patients: A Longitudinal Study. Hypertension, 39, 10-15. https://doi.org/10.1161/hy0102.099031
|
[52]
|
Chaosuwannakit, N., D’Agostino, R., Hamilton, C.A., Lane, K.S., Ntim, W.O., Lawrence, J., et al. (2010) Aortic Stiffness Increases upon Receipt of Anthracycline Chemotherapy. Journal of Clinical Oncology, 28, 166-172.
https://doi.org/10.1200/JCO.2009.23.8527
|
[53]
|
Drafts, B.C., Twomley, K.M., D’Agostino, R., Lawrence, J., Avis, N., Ellis, L.R., et al. (2013) Low to Moderate Dose Anthracycline-Based Chemotherapy Is Associated with Early Non-invasive Imaging Evidence of Subclinical Cardiovascular Disease. JACC: Cardiovascular Imaging, 6, 877-885. https://doi.org/10.1016/j.jcmg.2012.11.017
|
[54]
|
Grover, S., Lou, P.W., Bradbrook, C., Cheong, K., Kotasek, D., Leong, D.P., et al. (2015) Early and Late Changes in Markers of Aortic Stiffness with Breast Cancer Therapy. Internal Medicine Journal, 45, 140-147.
https://doi.org/10.1111/imj.12645
|